HOME >> MEDICINE >> NEWS
Dynavax Demonstrates Ability Of Immunostimulatory DNA Sequences To Inhibit Symptoms Of Allergic Asthma In Animal Model

BERKELEY, CA (December 15, 1998): Injections of proprietary immunostimulatory DNA sequences (ISS-DNA), under development by Dynavax Technologies Corporation, can alter the nature of the immune response in allergic asthma, while also inhibiting the symptoms of that disease, the company announced. Dynavax scientists and their collaborators published research in the December 15 issue of the Journal of Immunology showing that a single systemic or mucosal (intranasal or intratracheal) administration of ISS-DNA in an animal model of allergic asthma inhibited disease symptoms as effectively as systemic corticosteroids administered daily for seven days. Moreover, unlike the corticosteroids, ISS-DNA injections were able to redirect the immune response away from the strong Th2 response associated with allergic inflammation toward a non-allergic Th1 response.

"This study demonstrates in vivo, for the first time, that ISS-DNA can be used as a drug to both inhibit and modify allergic disease," said Dino Dina, M.D., president and chief executive officer of Dynavax. "In fact, our lead ISS-DNA molecule has proven active in every animal species that Dynavax scientists and their collaborators have tested to date, including primates. Based on their research, we believe that ISS-DNA therapy may provide a totally novel, highly effective therapy for chronic allergic pulmonary inflammation."

The Journal of Immunology study was authored by Dynavax founder, Eyal Raz, M.D. and David Broide, M.B. Ch.B. of the Department of Medicine, University of California, San Diego; and their collaborators Helen Tighe, Ph.D., Minh-Duc Nguyen, and Siamak Malek at Dynavax; Tim Gifford and John Van Uden at the University of California, San Diego; and Jurgen Schwarze, M.D. and Erwin W. Gelfand, M.D. at the Department of Pediatrics, National Jewish Medical and Research Center in Denver, CO.

In the study, the researchers used a mouse model of allergen-induced airway hyperresponsiveness to investi
'"/>

Contact: Joan Kureczka
jkureczka@aol.com
415-821-2413
Kureczka/Martin Associates
15-Dec-1998


Page: 1 2 3

Related medicine news :

1. Clinical Trial Demonstrates Experimental Growth Factor Increases Eligibility For Autologous Stem Cell Transplantation
2. New Report Demonstrates That Following Guidelines Improves Clinical Practices, Reduces Liability Costs
3. Study Demonstrates The Benefits Of Mammography In Women Under 50
4. Study Demonstrates Safety & Effectiveness Of Asthma Drug
5. Inhibitors prevent aggresome formation associated with some forms of ALS
6. Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice
7. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
8. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
9. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
10. Antabuse May Inhibit Fatal Reaction To Anesthetic
11. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Made of Millions, a nonprofit ... exhibit — Seen — to New York this month. The event will feature a ... to create environment that showcases mental health issues in a more experiential way,” said ...
(Date:11/15/2018)... ... 15, 2018 , ... Over the last decade, SABRE , the global ... for National Breast Cancer Foundation (NBCF) . A mission-driven organization and proud partner ... proceeds have helped launch the National Mammography Program which has provided almost ...
(Date:11/15/2018)... Ky. (PRWEB) , ... November 15, 2018 , ... ... Turner have recently invited four more skilled medical professionals to join their ... includes more procedures at its skin clinic, Skin Chic, and is expanding its ...
(Date:11/15/2018)... ... 15, 2018 , ... Mothers and babies across California are ... that puts vital health education resources right at their fingertips. The initiative between ... Plan effective 1/1/19), an affiliate of Blue Shield of California, and the ...
(Date:11/15/2018)... ... ... The National Cancer Institute estimates that 1.7 million new cases of cancer will ... and we typically associate the disease with old age, about 9 percent of cancers ... advanced therapies, increasing numbers of these patients survive their disease and face the consequences ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... Ric Henry, President and Owner of Pendulum, ... or Consequences, New Mexico on Friday, November 2, 2018. Ric, who opened Sierra as ... of Directors. , Sierra Health Care Center has become known as one of ...
(Date:11/15/2018)... ... 15, 2018 , ... American Bancard, dba TouchSuite announced today ... Canadian markets. TouchSuite will underwrite merchants selling CBD products online or in ... of the risks associated with the industry. CBD accounts will be boarded via ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... Joint ... orthopedic institution in the Midwest, is one of only nine group practice centers in ... Two of the most common surgeries Americans undergo each year—knee and hip replacement—will be ...
Breaking Medicine Technology:
Cached News: